Efficiency of nicotinamide-based supportive therapy in lymphopenia for patients with ordinary or severe COVID-19: A randomized controlled trial.

Hu, Qiang; Zhang, Quan-Yu; Peng, Cheng-Fei; Ma, Zhuang; Han, Ya-Ling

Hu, Qiang; Zhang, Quan-Yu; Peng, Cheng-Fei; Ma, Zhuang; Han, Ya-Ling.

Afiliación

Hu Q; Department of Cardiology, General Hospital of Northern Theater Command, Shenyang, China.
Zhang QY; Department of Cardiology, Air Force Hospital of Western Theater Command, Chengdu, China.
Peng CF; Department of Cardiology, General Hospital of Northern Theater Command, Shenyang, China.
Ma Z; Department of Cardiology, General Hospital of Northern Theater Command, Shenyang, China.
Han YL; Department of Respiratory and Critical Care Medicine, General Hospital of Northern Theater Command, Shenyang, China.

Medicine (Baltimore) ; 101(43): e31138, 2022 Oct 28.

Article en En | MEDLINE | ID: mdl-36316932

Asunto(s)

COVID-19; Linfopenia; Humanos; COVID-19/complicaciones; SARS-CoV-2; Niacinamida/uso terapéutico; Mortalidad Hospitalaria; Linfopenia/etiología

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 / Linfopenia Tipo de estudio: Clinical_trials / Etiology_studies Límite: Humans Idioma: En Revista: Medicine (Baltimore) Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google